Grants for Special District Governments

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) aims to support the clinical validation of already analytically validated biomarkers and assays for cancer detection, diagnosis, and treatment monitoring, ensuring they are reliable and ready for use in clinical studies without conducting new trials.

Grant Title: New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed) aims to fund innovative research to develop new treatments for genital herpes that can reduce viral shedding, prevent lesions, and lower transmission risks.

Grant Title: Artificial Intelligence and Machine Learning Applied to Nuclear Science and Technology - This grant aims to fund research that uses AI and machine learning to improve the efficiency and effectiveness of nuclear science experiments, particularly in optimizing accelerators, detectors, and data analysis.

Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required) aims to fund a Data Coordinating Center that will manage and analyze data for multi-site clinical trials focused on mind and body interventions, ensuring successful project coordination and compliance with regulatory standards.

This funding opportunity provides financial support for projects that improve school meal preparation using New York State farm products, reduce food insecurity, and promote workforce development in the food industry for eligible non-profits, municipalities, school districts, and educational service boards.

This funding opportunity provides up to $1 million to a wide range of organizations to develop a centralized resource for exploring and analyzing single-cell genomics data from the human brain, enhancing research on brain health and disease.

This funding opportunity is designed to help educational institutions and non-profit organizations create and support high school robotics teams across Texas, with a strong emphasis on inclusivity for students with disabilities.

NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD aims to support postdoctoral scientists from diverse backgrounds in developing skills for translational research on Alzheimer's Disease and Related Dementias through mentorship and targeted research experiences.

NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31) aims to support and develop promising predoctoral candidates from underrepresented backgrounds in Alzheimer's disease research by providing financial support and mentorship to enhance their skills in data science and drug discovery.

The "NCI National Clinical Trials Network - Network Lead Academic Participating Sites" grant is a funding opportunity from the National Cancer Institute for academic centers to provide scientific leadership and patient recruitment for large-scale, multi-institutional cancer clinical trials, with a focus on treatment trials, rare cancers, and underserved populations, offering up to $1.7 million per year for a six-year project period.

This funding opportunity supports researchers investigating new biological, environmental, and social factors contributing to liver cancer in the U.S., particularly in relation to established risk factors and health disparities.

This funding opportunity is designed for researchers with active NCI R01 grants to validate and enhance existing cancer biomarker assays, facilitating their clinical use and improving cancer detection and treatment strategies.

This funding opportunity supports ongoing clinical trials aimed at improving the diagnosis, prevention, and treatment of dental, oral, and craniofacial diseases, encouraging applications from a wide range of eligible institutions and organizations.

This funding opportunity supports U.S. institutions and organizations in developing centers that integrate advanced translational science into cancer clinical trials, enhancing research on precision medicine and rare cancers.

The "Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility" grant is a funding opportunity by the National Cancer Institute for research projects that aim to investigate new and existing risk factors of liver cancer, including biological, environmental, and social factors, to enhance understanding of the disease and inform prevention strategies in the U.S.

This program provides financial assistance to local organizations and landowners in Boulder County for large-scale wildfire risk reduction projects that enhance forest and grassland management.

This funding opportunity supports research projects that investigate individual differences in pain experiences and treatment responses, aiming to develop personalized pain management strategies while addressing the opioid crisis.

The "Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)" grant is a $2.5 million funding opportunity from the CDC and ATSDR, aimed at supporting research to better understand potential risk factors for ALS, with a focus on environmental and occupational exposures, military service, traumatic brain injury, neuroinflammation, contact sports, and infectious agents, especially in underrepresented populations.

This grant provides funding for U.S.-based nonprofit organizations and educational institutions to conduct archaeological and ethnographic field research that addresses significant humanities questions, with a focus on collaboration with local communities.

This funding opportunity supports neurologists and neurosurgeons in the NINDS intramural program as they transition to independent research-focused faculty positions at academic institutions.